Literature DB >> 21733225

Distinct periods of developmental sensitivity to the effects of 3,4-(±)-methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats.

Matthew R Skelton1, Devon L Graham, Tori L Schaefer, Curtis E Grace, Amanda A Braun, Lindsey N Burns, Robyn M Amos-Kroohs, Michael T Williams, Charles V Vorhees.   

Abstract

Previous findings showed allocentric and egocentric learning deficits in rats after MDMA treatment from postnatal days (PD) 11-20 but not after treatment from PD 1-10. Shorter treatment periods (PD 1-5, 6-10, 11-15, or 16-20) resulted in allocentric learning deficits averaged across intervals but not for any interval individually and no egocentric learning deficits individually or collectively. Whether this difference was attributable to treatment length or age at the start of treatment was unclear. In the present experiment rat litters were treated on PD 1-10, 6-15, or 11-20 with 0, 10, or 15 mg/kg MDMA q.i.d. at 2-h intervals. Two male/female pairs/litter received each treatment. One pair/litter received acoustic startle with prepulse inhibition, straight channel swimming, Cincinnati water maze (CWM), and conditioned fear in a latent inhibition paradigm. The other pair/litter received locomotor activity, straight channel swimming, Morris water maze (MWM), and locomotor activity retest with MK-801 challenge. MDMA impaired CWM learning following PD 6-15 or 11-20 exposure. In MWM acquisition, all MDMA-treated groups showed impairment. During reversal and shift, the PD 6-15 and PD 11-20 MDMA-treated groups were significantly impaired. Reductions in locomotor activity were most evident after PD 6-15 treatment while increases in acoustic startle were most evident after PD 1-10 treatment. After MK-801 challenge, MDMA-treated offspring showed less locomotion compared to controls. Region-specific changes in brain monoamines were also observed but were not significantly correlated with behavioural changes. The results show that PD 11-20 exposure to MDMA caused the largest long-term cognitive deficits followed by PD 6-15 exposure with PD 1-10 exposure least affected. Other effects, such as those upon MK-801-stimulated locomotion showed greatest effects after PD 1-10 MDMA exposure. Hence, each effect has a different window of developmental susceptibility.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21733225      PMCID: PMC4599583          DOI: 10.1017/S1461145711000952

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  26 in total

1.  Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: nonspatial pretraining eliminates spatial learning deficits.

Authors:  D Saucier; E L Hargreaves; F Boon; C H Vanderwolf; D P Cain
Journal:  Behav Neurosci       Date:  1996-02       Impact factor: 1.912

2.  Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats.

Authors:  Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

3.  Methamphetamine exposure from postnatal day 11 to 20 causes impairments in both behavioral strategies and spatial learning in adult rats.

Authors:  Michael T Williams; Charles V Vorhees; Francis Boon; Andrea J Saber; Donald P Cain
Journal:  Brain Res       Date:  2002-12-27       Impact factor: 3.252

4.  Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).

Authors:  E Ho; L Karimi-Tabesh; G Koren
Journal:  Neurotoxicol Teratol       Date:  2001 Nov-Dec       Impact factor: 3.763

5.  Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.

Authors:  Martha A Cohen; Matthew R Skelton; Tori L Schaefer; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Synapse       Date:  2005-09-01       Impact factor: 2.562

6.  Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress.

Authors:  Michael T Williams; LaRonda L Morford; Sandra L Wood; Stephanie L Rock; Anne E McCrea; Masao Fukumura; Tanya L Wallace; Harry W Broening; Mary S Moran; Charles V Vorhees
Journal:  Brain Res       Date:  2003-04-04       Impact factor: 3.252

7.  During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.

Authors:  Derek G Moore; John D Turner; Andrew C Parrott; Julia E Goodwin; Sarah E Fulton; Meeyoung O Min; Helen C Fox; Fleur M B Braddick; Emma L Axelsson; Stephanie Lynch; Helena Ribeiro; Caroline J Frostick; Lynn T Singer
Journal:  J Psychopharmacol       Date:  2009-11-25       Impact factor: 4.153

8.  (+/-)3,4-Methylenedioxymethamphetamine (MDMA) dose-dependently impairs spatial learning in the morris water maze after exposure of rats to different five-day intervals from birth to postnatal day twenty.

Authors:  Charles V Vorhees; Tori L Schaefer; Matthew R Skelton; Curtis E Grace; Nicole R Herring; Michael T Williams
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

9.  Developmental effects of +/-3,4-methylenedioxymethamphetamine on spatial versus path integration learning: effects of dose distribution.

Authors:  Charles V Vorhees; Tori L Schaefer; Michael T Williams
Journal:  Synapse       Date:  2007-07       Impact factor: 2.562

10.  Web-based method for translating neurodevelopment from laboratory species to humans.

Authors:  Barbara Clancy; Brandon Kersh; James Hyde; Richard B Darlington; K J S Anand; Barbara L Finlay
Journal:  Neuroinformatics       Date:  2007
View more
  3 in total

1.  MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density.

Authors:  Sònia Abad; Alberto Fole; Nuria del Olmo; David Pubill; Mercè Pallàs; Fèlix Junyent; Jorge Camarasa; Antonio Camins; Elena Escubedo
Journal:  Psychopharmacology (Berl)       Date:  2013-10-26       Impact factor: 4.530

Review 2.  Cincinnati water maze: A review of the development, methods, and evidence as a test of egocentric learning and memory.

Authors:  Charles V Vorhees; Michael T Williams
Journal:  Neurotoxicol Teratol       Date:  2016-08-18       Impact factor: 3.763

3.  Paradoxical effects of low dose MDMA on latent inhibition in the rat.

Authors:  A J D Nelson; K E Thur; C A Marsden; H J Cassaday
Journal:  Neuropharmacology       Date:  2012-11-29       Impact factor: 5.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.